Acute exposure to inhaled ambient particles is associated worldwide with adverse health effects (1) . The fraction of ultrafine particles (UFPs) in the ambient aerosol is considered as a major factor contributing to these effects (2) . Evidence for the involvement of chemically inert, very small particles in eliciting adverse health effects comes from animal experiments (3) . The hypothesis that the number of UFPs is more closely associated with adverse health effects than the mass of fine particles was recently supported in an epidemiologic study (4) . However, this hypothesis remains controversial. The surface area of particles might be another parameter that determines the biologic response of target cells or tissues (5) . To further elucidate the role of ultrafine particles in adverse health effects, we studied whether this particle fraction acts on mediator systems involved in physiologic responses of immune cells.
Lipid mediators may play a major role in promoting or eliciting responses of lung tissue to air pollutants such as ozone (6, 7) , sulfurrelated species, especially sulfite (8, 9) , silica (10, 11) , and residual oil fly ash (12) . Among the lipid mediators, platelet-activating factor and products of the 5-lipoxygenase (5-LO) pathway such as leukotriene B 4 (LTB 4 ) are known to stimulate immune cells such as polymorphonuclear neutrophil (PMNs) (13) (14) (15) . By contrast, prostaglandin E 2 (PGE 2 ), a major product of the cyclooxygenase (COX) pathway, counterbalances inflammatory reactions by suppressing defense functions of alveolar macrophages (AMs) or PMNs (16) (17) (18) (19) .
As part of the primary pulmonary defense system, AMs are important target cells whose major functions are a) the elimination of inhaled particles such as pathogens and b) the production of pro-and anti-inflammatory mediators including leukotrienes and prostaglandins. Related to these fundamental functions, we tested the hypothesis that UFPs and their agglomerates induce AMs to release lipid mediators in a manner dependent on the particle surface area, and that the particle-induced release of some of these mediators affects cellular defense mechanisms such as the respiratory burst of PMNs. We analyzed arachidonic acid (AA) as a primary product of phospholipase A 2 (PLA 2 ), the COX-derived mediators PGE 2 , thromboxane B 2 (TXB 2 ), 12-hydroxyheptadecatrienoic acid , and the 5-LO products LTB 4 and 5-hydroxyeicosatetraenoic acid (5-HETE). As model particles we used agglomerates of ultrafine particles (AUFPs) of elemental carbon (EC) and of titanium dioxide (TiO 2 ). The biologic effects of these UFPs were compared with those of agglomerates of fine particles (AFPs) of TiO 2 .
Materials and Methods

Materials
Phorbol 12-myristate 13-acetate (PMA) and lucigenin were purchased from Sigma (Deisenhofen, Germany); Polymorphprep was from Nycomed (Oslo, Norway); phosphate-buffered saline (PBS) with or without Ca 2+ /Mg 2+ was from Biochrom (Berlin, Germany); RPMI was from PAA Laboratories (Linz, Austria); fetal calf serum, penicillin, streptomycin and amphotericin were from Life Technologies (Eggenstein, Germany); [ 14 C]-AA was from Amersham Buchler (Braunschweig, Germany); indomethacin (1-(p-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid) and NS 398 (N-(2-cyclohexyloxy-4-nitrophenyl) methansulfonamide) were from Calbiochem (Bad Soden, Germany); all other chemicals (analytical or high-performance chromatography grade) were from Merck (Darmstadt, Germany).
Particle Characteristics
Ultrafine particles of EC were generated by spark discharging according to the method described by Roth et al. (20) . The airborne EC particles had a count median diameter of 77 nm and a specific surface area of 750 ± 150 m 2 /g (n = 50) as determined by adsorption of nitrogen (21) . Ultrafine TiO 2 particles with a diameter of 21 nm and a specific surface area of 50 m 2 /g were purchased from Degussa (Frankfurt, Germany). The fine TiO 2 particles with a diameter of 250 nm and a specific surface area of 6.5 m 2 /g were Agglomerates of ultrafine particles (AUFPs) may cause adverse health effects because of their large surface area. To evaluate physiologic responses of immune cells, we studied whether agglomerates of 77-nm elemental carbon [(EC); specific surface area 750 m 2 /g] and 21 nm titanium dioxide (TiO 2 ) particles (specific surface area 50 m 2 /g) affect the release of lipid mediators by alveolar macrophages (AMs). After 60-min incubation with 1 µg/mL AUFP-EC (corresponding to 7.5 cm 2 particle surface area), canine AMs (1 × 10 6 cells/mL) released arachidonic acid (AA) and the cyclooxygenase (COX) products prostaglandin E 2 (PGE 2 ), thromboxane B 2 , and 12-hydroxyheptadecatrienoic acid but not 5-lipoxygenase (5-LO) products. AUFP-TiO 2 with a 10-fold higher mass (10 µg/mL) than AUFP-EC, but a similar particle surface area (5 cm 2 ) also induced AMs to release AA and COX products. Agglomerates of 250 nm TiO 2 particles (specific surface area 6.5 m 2 /g) at 100 µg/mL mass concentration (particle surface area 6.5 cm 2 ) showed the same response. Interestingly, 75 cm 2 /mL surface area of AUFP-EC and 16 cm 2 /mL surface area of AUFP-TiO 2 additionally induced the release of the 5-LO products leukotriene B 4 and 5-hydroxyeicosatetraenoic acid. Respiratory burst activity of stimulated canine neutrophils was partially suppressed by supernatants of AMs treated with various mass concentrations of the three types of particles. Inhibition of neutrophil activity was abolished by supernatants of AMs treated with COX inhibitors prior to AUFP-incubation. This indicates that anti-inflammatory properties of PGE 2 dominate the overall response of lipid mediators released by AUFP-affected AMs. In conclusion, our data indicate that surface area rather than mass concentration determines the effect of AUFPs, and that activation of phospholipase A 2 and COX pathway occurs at a lower particle surface area than that of 5-LO-pathway. We hypothesize a protective role of PGE 2 prepared by repeated vortexing (5 times for 3 sec) and sonification (1 min) of the suspensions. Despite the vigorous mixing, these particles formed agglomerates as determined by microscopic determination. Therefore, during incubation in suspension, the cells were exposed to AFUPs and AFPs.
Alveolar Macrophages
Canine AMs were harvested by bronchoalveolar lavage of healthy beagles according to the method of Maier et al. (22) . Cells were recovered by centrifugation (400 × g for 20 min) and resuspended in PBS (without Ca 2+ /Mg 2+ ). Viability was more than 95% as determined by trypan blue exclusion. By microscopic examination of cytospin preparations after May Grünwald Giemsa staining, 85-90% of the cells were identified as AMs.
PMNs
Canine PMNs were isolated from citrate blood samples of healthy beagles by densitygradient centrifugation with Polymorphprep according to Beck-Speier et al. (8) . Blood (5 mL) was layered over Polymorphprep (5 mL) diluted with 1.5% (w/v) NaCl. After centrifugation (450×g for 30 min), separation from lymphocytes/monocytes, and removal of contaminating erythrocytes by hypotonic lysis, a pure population of PMNs (99 ± 1%; n = 3) was resuspended in PBS (without Ca 2+ /Mg 2+ ) containing 0.1% glucose. Viability was more than 95% as estimated by trypan blue exclusion.
AA Metabolites of AMs
Studies on the AA metabolism in particletreated AMs were performed as follows: Canine AMs (1 × 10 6 /mL) were preincubated for 2 hr at 37°C in RPMI medium containing penicillin (100 U/mL), streptomycin (100 U/mL), amphotericin B (2.5 µg/mL), 5% fetal calf serum, and labeled with [ 14 C]-AA (4 kBq/1 × 10 6 cells) in fresh medium for 20 hr. After removal of labeled medium and a preincubation for 30 min at 37°C in PBS, pH 7, containing Ca 2+ /Mg 2+ and 0.1% glucose, AMs were incubated with particles for 60 min at 37°C. Incubation was stopped by cooling to 4°C and [ 14 C]-lipids were extracted from a 1-mL suspension of AMs by addition of 3.75 mL chloroform/methanol (1:2). Phase separation was induced with an additional 1.25 mL of chloroform and 1.25 mL of 0.2% formic acid. The organic phase was collected, and the aqueous phase was extracted once again with chloroform (23) . After drying the organic phase under nitrogen, the metabolites were dissolved in chloroform and spotted onto high-performance thin-layer chromatography (HPTLC) plates (10 cm × 20 cm NanoDurasil-20 glass plates; Macherey & Nagel, Düren, Germany). Separation by thin-layer chromatography (TLC) was processed in a solvent system containing ethyl acetate/isooctane/acetic acid/water (10:5:2:10) according to the method of Krug and Berndt (24) . Values of control metabolites represent the radioactivity of the single metabolites in relation to the total radioactivity of the control cells. The radioactivity as percentage of total radioactivity of control cells was 1.97 ± 0.58 [7] for arachidonic acid, 0.43 ± 0.08 [7] for 12-HHT, 0.32 ± 0.11 [7] for 5-HETE, 0.40 ± 0.14 [7] for LTB 4 , and 0.62 ± 0.21 [7] for PGE 2 /TXB 2 . Numbers in brackets represent the number of experiments performed with AMs of different dogs. Asterisks indicate significance of difference between eicosanoid generation in control cells and particle-affected cells (*p < 0.05 and **p < 0.001). (B) Supernatants of AMs incubated in the absence (control) and presence of AUFP-EC were analyzed for their ability to stimulate CL in PMNs. CL is given as percentages (means ± SD) of CL response of resting PMNs incubated with supernatant of control AMs, which amounted to 3.031 ± 0.284 × 10 6 CL counts during 20 min per 1.5 × 10 4 cells [6] . Numbers in brackets represent the number of experiments performed with AMderived supernatants of different dogs. Asterisks indicate significance of difference between CL of PMA-stimulated PMNs assayed with supernatant of control AMs and supernatant of AMs incubated with particles (*p < 0.05 and **p < 0.001).
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Results
Generation of AA Metabolites by Particle-Induced AMs and Their Effect on Respiratory Burst Activity of PMNs
The effects of AUFP-EC as well as that of AUFP-TiO 2 on the formation of AA and the AA-derived COX metabolites 12-HHT and PGE 2 /TXB 2 and the 5-LO metabolites 5-HETE and LTB 4 are seen in Figure 1 . These metabolites were quantified compared to those of control cells. As shown in Figure 2A , AUFP-EC at 1 µg/mL mass concentration caused a 2-fold increase in generation of AA as well as the COX products 12-HHT and PGE 2 /TXB 2 by AMs compared to control cells. The production of the 5-LO products 5-HETE and LTB 4 was enhanced at ≥ 10 µg/mL AUFP-EC, i.e., at 10-fold higher mass concentrations. There was no further increase of eicosanoids at AUFP-EC concentrations of 100 µg/mL or 320 µg/mL (data not shown). In addition we assessed the influence of supernatants derived from particle-treated AMs on PMN defense function. Respiratory burst activity of PMAstimulated PMNs was reduced by supernatants of AMs incubated with AUFP-EC ( Figure 2B ). In contrast, there was no suppressive effect on PMN respiratory burst activity by supernatants obtained from control incubations with particles in absence of AMs (data not shown). This suggests the presence of an inhibitory factor produced by AMs exposed to AUFP-EC. To study whether COX metabolites are involved in the inhibitory effect of AM-derived supernatants, we pretreated AMs with the COX inhibitors either indomethacin or NS 398 before particles were added. As seen in Table  1 , supernatants from AM incubations with AUFP-EC in the presence of COX inhibitors did not reduce the respiratory burst activity of PMN. AUFP-TiO 2 induced AMs to generate AA, 12-HHT, and PGE 2 /TXB 2 at mass concentrations ≥ 10 µg/mL ( Figure 3A) , whereas the 5-LO products 5-HETE and LTB 4 were produced at mass concentrations 
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Control [9] Supernatants of AMs incubated with AUFP-TiO 2 (µg/mL) Figure 3B ). This decrease of PMN respiratory burst activity was not observed with supernatants derived from AMs treated with COX inhibitors prior to incubation with AUFP-TiO 2 (Table 1) . AFP-TiO 2 increased AA and the COX products 12-HHT and PGE 2 /TXB 2 in AMs at mass concentrations of 100 µg/mL, and the 5-LO products LTB 4 and 5-HETE at mass concentrations of 320 µg/mL ( Figure  4A ). These are markedly higher-particle mass concentrations than those used for AUFP-TiO 2 to produce a similar effect. The supernatants derived from AMs incubated with AFP-TiO 2 also reduced respiratory burst activity of PMA-stimulated PMNs ( Figure 4B) .
Control experiments showed that the viability of AMs after incubation with particles did not change compared to that of control cells (viability about 90 ± 2%, n = 2) as ascertained by trypan blue exclusion. The particles used in our study contained < 0.01% endotoxin as estimated by the Limulus amebocyte lysate assay (Charles River, Sulzfeld, Germany). Because endotoxin in various concentrations up to 10 µg/mL did not influence the formation of eicosanoids in canine AMs, a possible effect of an endotoxin contamination of the particles on the release of eicosanoids can be excluded.
Taken together our results indicate that for each type of particle AA and the COX products PGE 2 /TXB 2 and 12-HHT are generated at distinctly lower particle mass concentrations than the 5-LO products. The mediators present in the supernatants derived from particle-treated AMs are able to suppress PMN defense function. The mediators responsible for inhibition of PMN activity are COX dependent.
Relationship between Eicosanoid Production and Surface Area of the Particles
The particles used in this study have very different surface areas per mass. To evaluate which parameter of the particles determines the biologic response of AMs, we related the data on the generation of eicosanoids to the mass and surface area of the particles. As shown in Table 2 , a 2-fold initial increase of AA, PGE 2 /TXB 2 , and 12-HHT by AMs was seen at mass concentrations of 1 µg/mL for AUFP-EC, 10 µg/mL for AUFP-TiO 2, and 100 µg/mL for AFP-TiO 2 . However, these different mass concentrations correspond to very similar surface areas ranging between 5 and 7.5 cm 2 /mL for the three types of particles. This indicates that the initial release of AA and the COX products PGE 2 /TXB 2 and 12-HHT is induced by similar surface areas of the different types of particles. Table 3 shows a 2-fold initial increase of the 5-LO products LTB 4 and 5-HETE by AMs incubated with 10 µg/mL AUFP-EC, 32 µg/mL AUFP-TiO 2 , and 320 µg/mL. These particle mass concentrations correspond to surface areas ranging between 16 and 75 cm 2 /mL. Comparing both tables, it is apparent that the 5-LO products are released at higher particle surface areas than AA and the COX products.
Discussion
The present study demonstrates that AUFP-EC, AUFP-TiO 2 , and AFP-TiO 2 induce AMs to release AA as a metabolite of PLA 2 , PGE 2 , TXA 2 (detected as its inactive metabolite TXB 2 ), and 12-HHT as products of the COX pathway, and LTB 4 and 5-HETE as products of the 5-LO pathway. However, the dose-response of the 5-LO pathway to these particles is different from that of the PLA 2 and COX pathways. A 2-fold release of PLA 2 -and COX-related metabolites by AMs occurs at a mass concentration of 1 µg/mL for AUFP-EC but at a 10-fold higher mass concentration for AUFP-TiO 2 and 100-fold higher mass concentration for AFP-TiO 2 ( Table 2 ). This initial increase of AA, 12-HHT, and PGE 2 /TXB 2 was followed by a further gradual increase up to 300-400% of baseline level for increasing particle mass concentrations (Figures 2A, 3A, 4A) . Interestingly, the very different mass concentrations of the three types of particles needed for the initial release of AA and COX products correspond to similar surface areas within a range of 5-7.5 cm 2 /mL ( Table 2 ). This implies that the surface area rather than the mass concentration of the particles determines the biologic response of AMs to the particles. This conclusion is supported by findings of Oberdörster et al. (5) showing that after instillation in rats the increased pulmonary toxicity of ultrafine TiO 2 particles was related to their large surface area. Compared to AA and the COX products, the initial increase of the 5-LO-derived metabolites LTB 4 and 5-HETE is induced at substantially higher mass concentrations for each type of particle corresponding to surface areas ranging between 16 and 75 cm 2 /mL ( Table 2) . This indicates that a higher particle surface area is needed for an initial activation of the 5-LO pathway than for that of PLA 2 and the COX pathway. A further increase of particle mass concentrations led to a further increased release of 5-LO products up to 500% of baseline level. At high surface area, AUFP-TiO 2 cause a stronger response on Figure 2A . The radioactivity as percentage of total radioactivity of control cells was 1.78 ± 0.51 [7] for AA, 0.40 ± 0.14 [7] for 12-HHT, 0.22 ± 0.13 [7] for 5-HETE, 0.37 ± 0.19 [7] for LTB 4 , and 0.67 ± 0.41 [7] for PGE 2 /TXB 2 . (B) Supernatants of AMs incubated in the absence (control) and presence of AFP-TiO 2 were analyzed with PMNs according to legend for Figure 2B . The control value was 2.624 ± 0.488 × 10 6 CL counts during 20 min per 1.5 × 10 4 cells [7] . 32 [7] 100 [4] 320 [5] Control [7] Supernatants of AMs incubated with AFP-TiO 2 (µg/mL) 32 [7] 100 [4] 320 [7] B AA 12-HHT PGE 2 /TXB 2 5-HETE LTB 4 Resting PMNs PMA-stimulated PMNs eicosanoid release than AUFP-EC, which might be due to the different chemical composition of both types of particles. In our study the marked response of the respiratory burst activity of PMNs to the supernatants of AUFP-treated AMs could be triggered by the mixture of the various lipid mediators present in the supernatants. Inhibition of COX in AUFP-treated AMs abolished the inhibitory effect of the conditioned supernatants on PMN activity (Table  1) . Because COX exists in two isoforms, COX-1 and COX-2, we have used the COX inhibitors indomethacin and NS 398 in concentrations sufficient for each of them to inhibit both isoforms (27) . Among the COXdependent metabolites, PGE 2 is known to suppress the respiratory burst activity of PMA-stimulated PMNs (18) , whereas the 5-LO-dependent mediators LTB 4 and 5-HETE are able to activate oxygen radical production (28, 29) . The 5-LO products are released from AMs at substantially higher particle surface areas in the incubations than the COX products such as PGE 2 . Because the inhibitory effect on the PMN activity is seen with AM-derived supernatants obtained by both low and high amounts of particle surface area, we conclude that PGE 2 is the predominant mediator for the response of PMNs in this system. A possible stimulating effect of the 5-LO products released at higher particle surface area seems to be suppressed by PGE 2 .
PGE 2 is considered an anti-inflammatory mediator because it suppresses the release of cytokines such as interleukin (IL)-1 and tumor necrosis factor-α (TNF-α) (16, 17, 30, 31) and downregulates leukotriene synthesis (15) . This is consistent with reports documenting that PGE 2 upregulates the synthesis of IL-6, which is known to inhibit the production of IL-1β and TNF-α (32), and of IL-10, which plays a crucial role in terminating inflammatory processes (33) .
We have shown that PGE 2 plays a key regulatory role in the response of AMs to AUFPs in vitro. We therefore hypothesize that AM-derived PGE 2 downregulates initial inflammatory reactions, which might be induced by inhaled AUFPs in vivo to protect the lungs against inflammatory injury and/or to minimize adverse effects. This protecting function of PGE 2 may be the case for healthy individuals without symptoms of pulmonary and cardiovascular diseases. For patients having chronic pulmonary problems, the protecting role of PGE 2 may be overwhelmed by ongoing inflammatory processes including responses of inflammatory cells such as PMNs to inhaled particles.
In several reports an increased production of PGE 2 was described during in vitro and in vivo exposure studies with various particulate matter. Mohr et al. (10) reported that AMs of rats exposed to silica with a recovery period of several months showed an increased level of PGE 2 and TXB 2 that occurred after the elevated TNF-α release declined. These authors concluded that AMs of silica-exposed rats display an enhanced PGE 2 production that could serve anti-inflammatory and immunomodulating roles in silicosis. This is in agreement with findings of Englen et al. (34) who reported that silica at low doses caused the release of the COX products PGE 2 , TXB 2 , PGF 2 , and 12-HHT, whereas the metabolites of 5-LO were not produced. However, at higher doses the 5-LO products LTB 4 and 5-HETE were also generated accompanied by an increase in cytotoxicity of the silica particles. Kuhn et al. (35) showed that AMs of active coal miners displayed a marked increase in the production of PGE 2 , TXB 2 , IL-1β, and TNF-α and a reduction of LTB 4 , compared to normal volunteers and inactive coal miners. Despite their occupational exposure to coal dust, these miners did not have severe respiratory symptoms, which might be explained by their elevated PGE 2 levels protecting the lungs against inflammatory injury. AMs exposed in vitro to freshly fractured coal dust showed elevated levels of PGE 2 and TXB 2 but normal levels of LTB 4 , whereas exposure to silica activated the production of all three eicosanoids (36) . Taken together these reports show an activation of the COX pathway with a concomitant release of PGE 2 by lower amounts of particulate matter, leading to reduced inflammatory responses. At higher particle mass concentrations the proinflammatory mediator LTB 4 is produced in greatest generation, which also depends on the chemical composition of the particles. All these findings support our hypothesis that PGE 2 protects against adverse effects of low amounts of inhaled particles. Interestingly, Oberdörster et al. (5) have shown that ultrafine TiO 2 particles phagocytized by AMs and then instilled into rats did not elicit the inflammatory responses caused by the particles alone. This is consistent with a possible protective role of PGE 2 , which downregulates the inflammatory potency of AMs after uptake of particles.
How AUFP-EC and AUFP-TiO 2 stimulate AMs to release eicosanoids and which signal transduction mechanisms are involved is not currently known. From a cellfree in vitro system we have obtained evidence that the large surface area of AUFPs potently oxidizes methionine to methionine sulfoxide, indicating the formation of oxygen radicals (37) . We therefore suggest that during interaction with membranes the oxidative potential of AUFPs may initiate radical reactions leading to the activation of PLA 2 , which hydrolyzes phospholipids with polyunsaturated fatty acids to protect against lipid peroxidation (38) . AA generated during hydrolysis of correspondingly substituted phospholipids may be metabolized by COX, initiating the formation of PGE 2 , and by 5-LO, leading to production of 5-HETE and LTB 4 . Because these eicosanoids are potential mediators in stimulating inflammatory 
